Tonix Pharmaceuticals Holding (TNXP) Other Operating Expenses (2020 - 2026)

Tonix Pharmaceuticals Holding has reported Other Operating Expenses for 5 years, with the latest figure at $703000.0 in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 78.51% year-over-year to $703000.0 in Q2 2026; TTM through Jun 2026 was $4.7 million, a 32.32% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 90.05% from the prior year.
• Other Operating Expenses was $703000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, down from $1.6 million in the prior quarter.
• The five-year high for Other Operating Expenses was $62.3 million in Q2 2024, with the low at $703000.0 in Q2 2026.
• Average Other Operating Expenses over 4 years is $6.7 million, with a median of $1.6 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses plunged 94.75% in 2025, then jumped 67.34% in 2026.
• Over 4 years, Other Operating Expenses stood at $2.4 million in 2023, then plunged by 50.02% to $1.2 million in 2024, then declined by 10.57% to $1.1 million in 2025, then sank by 33.55% to $703000.0 in 2026.
• The last three Other Operating Expenses figures came in at $703000.0 (Q2 2026), $1.6 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.